Vector Space Biosciences 和 Advacam 合作绘制太空辐射图并为新航天工业经济开发人工智能模型

VSB (SBIO) 和 Advacam 将合作设计和开发 CubeSats，以及测量辐射和发射生物技术有效载荷

Advacam and Vector Space Biosciences (crypto: $SBIO) have signed a Letter of Intent (LOI) to collaborate on satellite payload design and development for CubeSats. Together, they aim to measure radiation and launch payloads for biotechnology, pharmaceutical companies, and space radiation hardening of medical device chipsets.

Advacam 和 Vector Space Biosciences（加密货币：$SBIO）签署了一份意向书 (LOI)，就 CubeSats 的卫星有效载荷设计和开发进行合作。他们共同致力于测量辐射并为生物技术、制药公司和医疗设备芯片组的空间辐射加固发射有效载荷。

This collaboration will involve launching Advacam's Timepix2 radiation detectors on VSB's CubeSats to measure Galactic Cosmic Rays (GCRs) and other forms of radiation in Low Earth Orbit (LEO). The data collected will be used to assess the impact of radiation on biological payloads, such as Waterbears (Tardigrades), and to optimize the hardening of AI semiconductors and other chipsets for space applications.

此次合作将涉及在 VSB 的 CubeSat 上发射 Advacam 的 Timepix2 辐射探测器，以测量银河宇宙射线 (GCR) 和近地轨道 (LEO) 中的其他形式的辐射。收集的数据将用于评估辐射对水熊虫（缓步动物）等生物有效载荷的影响，并优化人工智能半导体和其他太空应用芯片组的强化。

VSB's first launch, scheduled for Q1/Q2 2025 (or sooner), will include approximately 50 Waterbears and the Timepix2 detector. The company aims to achieve 2-3+ launches per week, with each launch carrying multiple payloads and up to 10 CubeSats. VSB and Advacam partners and customers will have the opportunity to sponsor each CubeSat launch.

VSB 的首次发射计划于 2025 年第一季度/第二季度（或更早）进行，将包括大约 50 个 Waterbears 和 Timepix2 探测器。该公司的目标是每周实现 2-3 次以上的发射，每次发射携带多个有效载荷和最多 10 个立方体卫星。 VSB 和 Advacam 合作伙伴及客户将有机会赞助每次 CubeSat 的发射。

Each payload generates valuable data that is modeled using an ensemble of proprietary and best-in-class targeted language models. This data can be used to identify hidden relationships and generate new discoveries in biotechnology, pharmaceuticals, and space technology.

每个有效负载都会生成有价值的数据，这些数据是使用专有且一流的目标语言模型集合进行建模的。这些数据可用于识别隐藏的关系并在生物技术、制药和空间技术领域产生新的发现。

Companies like Merck and Bristol Myers are leading the way in using data from space to develop more effective or new kinds of drug compounds.

默克（Merck）和百时美施贵宝（Bristol Myers）等公司在利用太空数据开发更有效或新型药物化合物方面处于领先地位。

Advacam and VSB will collaborate on points described in the LOI, such as:

Advacam 和 VSB 将就意向书中描述的要点进行合作，例如：

* Enabling revenue-sharing with customers, including biotechnology, pharmaceutical and AI semiconductor customers to take snapshots and measure space radiation including Galactic Cosmic Rays (GCRs) and high-charge, high-energy particles (HZEs) via the Advacam MiniPix Sprinter (Timepix2).

* 与生物技术、制药和人工智能半导体客户等客户分享收入，通过 Advacam MiniPix Sprinter (Timepix2) 拍摄快照并测量空间辐射，包括银河宇宙射线 (GCR) 和高电荷、高能粒子 (HZE) 。

* Launching the devices into Low Earth Orbit (LEO), following the same orbit as the ISS to generate reports for precision, accuracy, optimizations.

* 将设备发射到近地轨道 (LEO)，遵循与国际空间站相同的轨道，生成精度、准确度和优化报告。

* Constructing historical flight heritage logs for Advacam.

* 为 Advacam 构建历史飞行遗产日志。

* Vacuum case testing in LEO

* LEO 真空箱测试

* Providing joint marketing and PR along with customer referrals.

* 提供联合营销和公关以及客户推荐。

* Collaborating on detailed AI modeling and analysis of GCRs and HZE particles along with data snapshots and timestamps.

* 协作对 GCR 和 HZE 粒子以及数据快照和时间戳进行详细的 AI 建模和分析。

* Advacam and VSB will jointly work together to provide extended and advanced AI services in the analysis of datasets associated with VSB customer CubeSat payloads based on VSB’s work at Lawrence Berkeley National Laboratory and VSB Scientific Advisory Board (SAB).

* Advacam 和 VSB 将基于 VSB 在劳伦斯伯克利国家实验室和 VSB 科学咨询委员会 (SAB) 的工作，共同合作，提供扩展和先进的人工智能服务，用于分析与 VSB 客户 C​​ubeSat 有效载荷相关的数据集。

About Vector Space Biosciences

关于向量空间生物科学公司

VSB develops AI models with data from the space industry, enabling biotechnology, pharmaceutical, and AI semiconductor customers to launch payloads via CubeSats, to develop new drug compounds and radiation-harden AI semiconductors. The data from biological payloads and AI modeling (language modeling) can be used to develop new forms of precision medicine related to human aging and cancer or provide insights into radiation’s effect on AI semiconductors used in data centers being built in space today. Our primary goal connects to understanding how to develop countermeasures against stressors on the human body during spaceflight, like microgravity and radiation, resulting in new forms of precision medicine for all mankind. VSB maintains the crypto: $SBIO, a utility token based in Dubai and parent company to VXV and other spinoffs in the space and precision medicine industry. More information can be found here: https://vectorspacebio.science/technology

VSB 利用航天工业的数据开发人工智能模型，使生物技术、制药和人工智能半导体客户能够通过 CubeSats 发射有效载荷，开发新的药物化合物和抗辐射人工智能半导体。来自生物有效载荷和人工智能建模（语言建模）的数据可用于开发与人类衰老和癌症相关的新型精准医学，或深入了解辐射对当今太空中建造的数据中心所使用的人工智能半导体的影响。我们的主要目标是了解如何制定针对太空飞行期间人体压力源（例如微重力和辐射）的对策，从而为全人类带来新形式的精准医疗。 VSB 维护加密货币：$SBIO，这是一种位于迪拜的实用代币，也是 VXV 以及太空和精准医疗行业其他衍生公司的母公司。更多信息可以在这里找到：https://vectorspacebio.science/technology

Contacts

联系方式

Christopher Bartlett

克里斯托弗·巴特利特

chris@thinkgem.com

chris@thinkgem.com

203-494-4806

203-494-4806

support@vectorspacebio.science | Reddit | Telegram | Discord | twitter

支持@vectorspacebio.science |红迪网 |电报 |不和谐 |叽叽喳喳